U.S. Market for Infusion Therapy Devices (Executive Summary)
iData Research, March 2013
The U.S. infusion therapy device market will be driven by growth in the needleless connector market, which is expected to increase in value by over 50% during the forecast period.
In 2012, the U.S. market for infusion therapy devices was valued at just under $1.5 billion, a 3.2% increase over the previous year. This market includes infusion pumps, intravenous (IV) sets, and needleless connectors (NLCs). Infusion pumps are further segmented into large volume, syringe, patient-controlled analgesia (PCA), electronic ambulatory and disposable ambulatory infusion pumps. Growth in this market is expected to be driven by strong growth in the needleless connector market as the industry moves towards making procedures completely needle-free, and by growth in the disposable ambulatory infusion pump market as the number of infusion therapies performed in alternate or home care settings increases.
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S.
Report Contents:
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment & Country
- Trend Analysis by Segment & Country
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback and Market Monitoring
- Main Segments Included:
- Large Volume Infusion Pumps
- Syringe Infusion Pumps
- Patient-Controlled Analgesia Infusion Pumps
- Electronic Ambulatory Infusion Pumps
- Disposable Ambulatory Infusion Pumps
- Intravenous Set Market
- Primary IV Sets
- Secondary IV Sets
- IV Extensions Sets
- Needleless Connector Market
- Split Septum and Blunt Cannula
- Mechanical Valves
Also available
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network